The immune paradox of sarcoidosis and regulatory T cells. - Wikidata - awgldk - TriplyDB

The immune paradox of sarcoidosis and regulatory T cells.

The immune paradox of sarcoidosis and regulatory T cells.

http://www.wikidata.org/entity/Q36228289

about

XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma Etiology of sarcoidosis: does infection play a role?A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity Venous thromboembolism and sarcoidosis: co-incidence or coexistence?Granuloma formation in pulmonary sarcoidosis Sarcoidosis: Immunopathogenesis and Immunological Markers Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.Bronchoalveolar lavage fluid IFN-γ+ Th17 cells and regulatory T cells in pulmonary sarcoidosis T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.An in silico modeling approach to understanding the dynamics of sarcoidosis Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.Quantitative in situ analysis of FoxP3+ T regulatory cells on transplant tissue using laser scanning cytometry.Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.CD4+Foxp3+ T-regulatory cells in noninfectious uveitis.Sarcoidosis--scientific progress and clinical challenges.Renal transplantation in patients with sarcoidosis: a French multicenter study Regulatory T cells in many flavors control asthma Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.Adaptive immune responses in primary cutaneous sarcoidosis Dual therapy with cidofovir and mirtazapine for progressive multifocal leukoencephalopathy in a sarcoidosis patient.Regulatory T cells accumulate in the lung allergic inflammation and efficiently suppress T-cell proliferation but not Th2 cytokine production.Reduced expression of peroxisome proliferator-activated receptor alpha in BAL and blood T cells of non-löfgren's sarcoidosis patients.Harnessing regulatory T cells for the treatment of inflammatory bowel disease.Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans Serum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways.The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal T-bet and interleukin-27: possible TH1 immunomodulators of sarcoidosis Impaired survival of regulatory T cells in pulmonary sarcoidosis.Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients Increased levels of Treg cells in bronchoalveolar lavage fluid and induced sputum of patients with active pulmonary sarcoidosis Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.Abnormalities in iNKT cells are associated with impaired ability of monocytes to produce IL-10 and suppress T-cell proliferation in sarcoidosis.Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner?Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease.Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis

P2860

Q24318773-C42083AA-9C71-42F9-B6A4-D02E2D9B01B6 Q24608971-CEDAA4AC-17BB-4ED1-838E-BCBDA95B3D70 Q24622687-F8E03C34-10CE-4894-8482-C5DEEB0B46A7 Q26767140-4D4DD282-7993-4073-9BA0-4961E9238CA9 Q26863703-D8EC6867-B18E-4694-930A-3418C64F7E74 Q27006756-FF8524B1-C119-40F9-B65C-918D8F24CF43 Q28385953-AD3A1146-9D39-4979-9233-C19D5E335E5A Q31087724-38A66591-9AA5-4A1F-AAFB-96998553997B Q33591032-1291EE73-7F79-4DED-BC21-C0F8E6EDF410 Q33606850-BA96FF15-7C2F-4B08-A7E2-7F965792B4DF Q33634994-9ECB9C1C-E90F-45B4-8154-4899B6843426 Q33679052-ADB9AB80-F59D-4BB2-B159-B69D2C66D2D8 Q33921040-D588172E-B3DD-4627-9A29-A351F5AC17D6 Q33938362-3544FCFB-AC21-4F0A-A060-CCB5F12AD0F4 Q34022412-A0AA49F5-2CEE-4268-BCD8-7F81B1065690 Q34044170-C1310422-67D2-418E-B49B-6F58D80189D4 Q34085769-2037D0BA-7C21-4C4B-8C9F-B11109F81FCE Q34199947-A8AF7450-7401-4BBC-9142-1A45ACB52D27 Q34405427-B41BF29C-0074-4DC6-A81A-754287A19B44 Q34574231-5A2AFFAD-5AFF-4AF7-8ECF-33557D697650 Q34611407-0C3BA3B4-3E4C-4047-A5DC-086B47F81766 Q34975035-40C13B06-5EC7-40D0-8157-723D45EFA8A5 Q34983255-54336CF1-697A-4560-B76A-94FB5340AD68 Q35563801-7D94B804-497F-41CA-B0AB-0DC29B1DA62D Q35582278-8B0262A1-C018-43D9-BB40-F2F45968FA9D Q35596809-BA90BC81-A7CF-4789-9461-1DFF8CBBB2D2 Q35624877-85637006-16B7-4F63-AE60-DCD304E694D0 Q35740445-A7975901-71BA-4A14-849B-6D98E8D85A87 Q35812125-FD12CA74-BA83-4DA6-B350-0F3EA0668598 Q35914526-470E7554-E59A-4572-AF0C-EB9D86D31862 Q36054674-F5DF3368-55CC-49E7-8BC2-CF8848C2F0D8 Q36071176-7C125937-1D2F-40E8-8B5D-5CE021619ECB Q36127251-57ABB475-A057-4A2E-8492-E1B57F6602F5 Q36464091-59714F5B-3679-437E-8E30-38BA4463AC56 Q36498459-30A64A11-C63E-4E3F-89F1-672FA5C4D99E Q36560415-A4A7E19E-C968-4F31-B240-B9377E72C9E0 Q36728670-C44A501A-608C-4704-AA38-3AE0370F32D2 Q36738614-0E61DD0F-1339-4C6C-9930-36493DF715C6 Q36846993-8E985BFC-8198-4BC6-94C4-768046C2F924 Q36864267-78A3C7F9-9298-4729-AB9B-55A83B07C33C

P2860

The immune paradox of sarcoidosis and regulatory T cells.

http://www.wikidata.org/entity/Q36228289

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

The immune paradox of sarcoidosis and regulatory T cells.

@ast

The immune paradox of sarcoidosis and regulatory T cells.

@en

type

label

The immune paradox of sarcoidosis and regulatory T cells.

@ast

The immune paradox of sarcoidosis and regulatory T cells.

@en

prefLabel

The immune paradox of sarcoidosis and regulatory T cells.

@ast

The immune paradox of sarcoidosis and regulatory T cells.

@en

P1433

Q36228289-3DC15F81-ABB2-4C77-9734-088D88FADC86

P1476

Q36228289-0E616E67-9584-4E16-A73F-C66C5A065E95

P2093

Q36228289-0D318294-89F1-4B63-8185-3BA6072059F6

Q36228289-1E224A23-AB8D-4CC1-A0D4-78F989AFFEAA

Q36228289-1F8C2242-DC69-45F9-BADA-2CB8678A98FB

Q36228289-31734AAD-60B2-46E3-A6D6-9071EE007D26

Q36228289-409DB46B-0E93-4E14-8DAC-BE2CB7269D5B

Q36228289-64EE1F46-141A-41B1-A2AB-7497D6BA10CC

Q36228289-8A0A5DA7-04CB-46C0-AF2A-68008A16C689

Q36228289-D1FC8CEC-9C64-46F4-9A8D-26FFA72EB4C9

Q36228289-FFBAAD0A-078C-4044-BA60-0B5CCCFF1874

P2860

Q36228289-0CD33925-D1EB-4D48-B38F-4941DED06D9A

Q36228289-0E017100-70E9-45F8-9587-5EA29B9F8B28

Q36228289-0FB86DEE-3B96-4CF0-94F7-A0F1AB32A7C6

Q36228289-10462782-7F41-4579-973A-CE77BC12FB3C

Q36228289-1D5B7B30-1006-4578-99BC-4E0E43C86CF4

Q36228289-2999957E-31A3-46D9-A905-3E78610A3B4D

Q36228289-2B17AF4B-95A2-432C-8496-0CFF6592382B

Q36228289-2D56993C-3A8B-40D1-9E1D-4B4D8AC50547

Q36228289-2FADDE21-3576-4DB0-A449-4BAC9E3233E0

Q36228289-3A8E150E-4313-4777-A7D6-6CA1E62780EF

P304

Q36228289-CABA3C17-B6AF-447B-BB0B-D81B780F3EAF

P31

Q36228289-C2BE9E6F-7934-4477-B6EF-A97E37A3F148

P356

Q36228289-DDD6B0FC-2637-4081-AD77-39EE529BB890

P407

Q36228289-DAB5B292-8FD8-4464-B581-4350E002DA9B

P433

Q36228289-EA0586F2-992B-4DBF-A6EF-5418785D676C

P478

Q36228289-7AD67515-BBEE-49C3-8D2F-960FECACB5DD

P50

Q36228289-0C7EF68F-F791-43CB-94CE-AF8CBA604BB9

Q36228289-222F384A-0FC9-443A-AF48-50AAE9C72AE2

Q36228289-F4253D45-CAB4-420F-8721-1D2C598B9AEB

P577

Q36228289-796AA17F-A5F8-45F3-BEA6-B3A9F48224D1

P5875

Q36228289-24ECA0C3-8464-4436-8F29-0BC11E378052

P698

Q36228289-EDDFE3D5-2C33-4D69-899C-E0E168023464

P932

Q36228289-7406A431-95A0-49A0-BD07-54D39C9C0BFF

P356

P1433

Journal of Experimental Medicine

P1476

The immune paradox of sarcoidosis and regulatory T cells.

@en

P2093

Catherine Chapelon-Abric

http://www.w3.org/2001/XMLSchema#string

Christophe Parizot

http://www.w3.org/2001/XMLSchema#string

Cécile Badoual

http://www.w3.org/2001/XMLSchema#string

Dominique Valeyre

http://www.w3.org/2001/XMLSchema#string

Guy Gorochov

http://www.w3.org/2001/XMLSchema#string

Karim Dorgham

http://www.w3.org/2001/XMLSchema#string

Makoto Miyara

http://www.w3.org/2001/XMLSchema#string

Marianne Kambouchner

http://www.w3.org/2001/XMLSchema#string

Salim Trad

http://www.w3.org/2001/XMLSchema#string

P2860

Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

An essential role for Scurfin in CD4+CD25+ T regulatory cells

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

Increased risk for cancer following sarcoidosis.

P304

359-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050648

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Charles Piette

P577

2006-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7341455

http://www.w3.org/2001/XMLSchema#string

P698

16432251

http://www.w3.org/2001/XMLSchema#string

P932

2118208

http://www.w3.org/2001/XMLSchema#string